AI Article Synopsis
- The study aimed to assess the effectiveness and safety of zuranolone, an oral medication for postpartum depression (PPD), by comparing it to a placebo in randomized trials.
- A systematic search identified 11 relevant papers, leading to a detailed analysis of 2 studies involving 346 women, where zuranolone showed significant improvements in depression symptoms and reduced need for other antidepressants.
- While zuranolone appeared to be safe and effective for treating PPD, concerns about increased sedation risk necessitate further investigation.
Article Abstract
Objective: To evaluate the maternal outcomes in women with postpartum depression using zuranolone, the first oral medication indicated to treat postpartum depression.
Methods: We conducted a systematic search in September 2023, on Pubmed, Embase and Cochrane Trials. We included randomized controlled trials comparing the effectiveness and safety of zuranolone versus placebo in women with postpartum depression. No time or language restrictions were applied. 297 results were retrieved, of which 11 papers were selected and fully reviewed by two authors. Review Manager 5 was used for statistical analysis and Cochrane Risk-of-bias tool for randomized trials was applied for quality assessment.
Results: We included 2 studies, with 346 women, of whom 174 (50.2%) were treated with zuranolone. Zuranolone was significantly associated to an improvement of Clinical Global Impression response rate; Hamilton Depression Rating Scale 15 days and 45-day remission, 3-day, 15-day, and 45-day symptom remission, and reduction in the dose of antidepressants. As for safety outcomes, it was noticed that zuranolone increases sedation risk, which can be dose related. No significant differences were found for other adverse events.
Conclusion: These findings suggest that zuranolone might present a safe and effective medication for out-of-hospital treatment of PPD. Sedation effects need to be further assessed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637452 | PMC |
| http://dx.doi.org/10.61622/rbgo/2024rbgo79 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of epidural esketamine versus sufentanil on labor analgesia and postpartum depression: a retrospective cohort study.
BMC Anesthesiol
January 2025
Department of Anesthesiology, The Third Affiliated Hospital of Zhengzhou University, No. 7, Zhengzhou Kangfufront Street, Zhengzhou, Henan, 450052, China.
Objective: There is a lack of research on epidural esketamine for labor analgesia. The purpose of this research is to compare the efficacy of epidural esketamine and sufentanil on labor analgesia and postpartum depression.
Methods: A total of 187 cephalic full-term parturients with single-fetus vaginal delivery were collected in this retrospective study from Jan 2022 to Jan 2023.
A Plasma Proteomics-Based Model for Identifying the Risk of Postpartum Depression Using Machine Learning.
J Proteome Res
January 2025
Department of Traditional Chinese Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, China.
Postpartum depression (PPD) poses significant risks to maternal and infant health, yet proteomic analyses of PPD-risk women remain limited. This study analyzed plasma samples from 30 healthy postpartum women and 30 PPD-risk women using mass spectrometry, identifying 98 differentially expressed proteins (29 upregulated and 69 downregulated). Principal component analysis revealed distinct protein expression profiles between the groups.
View Article and Find Full Text PDFTreatment Advances in Perinatal Depression: Innovations and Promising Approaches.
J Clin Med
December 2024
Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
: Psychotherapy and antidepressants are the standard treatment for depression during pregnancy or postpartum. However, several new treatments for depression represent major advances and paradigm changes. This commentary highlights some innovative treatment options that are on the horizon.
View Article and Find Full Text PDFAssociation Between Postpartum Depression and Personality Traits Among Japanese Postpartum Mothers and Fathers.
J Clin Med
December 2024
Department of Clinical Psychology, Graduate School of Medicine, Kagawa University, Takamatsu 761-0793, Japan.
: Although numerous investigations have been conducted on postpartum depression, studies on the association between postpartum depression and personality traits of mothers and fathers are lacking. This study aimed to examine the association between postpartum depression and the Big Five personality models among Japanese mothers and fathers at one-month health check-ups. : The participants were 82 couples, and they responded to the Edinburgh Postnatal Depression Scale (EPDS), the Japanese version of the Ten-Item Personality Inventory, and the Quality of Marriage Index (QMI).
View Article and Find Full Text PDFDevelopment of a Japanese Version of the Parenting Sense of Competence Scale, and Examining the Structure of Japanese Mothers' Parenting Self-Efficacy.
Children (Basel)
November 2024
Faculty of Global Nursing, Otemae University, 2-1-88, Otemae, Chuo-ku, Osaka-shi 540-0008, Osaka, Japan.
Objective: Parenting self-efficacy (PSE) is an important factor in children's development. Mothers' PSE tends to be the lowest 1 month postpartum. A common measure of PSE is the Parenting Sense of Competence (PSOC) scale.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!